Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 2405171.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this trial, 381 women with invasive breast cancer in histopathologic stage I had sector resection with meticulous control for complete excision of local disease plus axillary dissection. We then randomly assigned 187 women to receive postoperative radiotherapy to a total mean dose of 54 Gy to the breast and 194 women to receive no further treatment. Criteria for eligibility were (a) a unifocal tumor 20 mm or less in diameter that was visible on a mammogram and (b) negative axillary lymph nodes on histopathologic examination. The mean follow-up time was 32.9 +/- 2.2 (SD) months in the group of patients treated with radiation and 29.3 +/- 2.4 months in the group treated with surgery alone. The actuarial local recurrence rate after 3 years was 2.9% (95% confidence interval, 0.1%-5.8%) in the group treated with radiation and 7.6% (95% confidence interval, 3.0%-12.3%) in the group treated with surgery alone (P = .06). The two treatment groups did not differ significantly in overall survival (P = .49) or survival free from regional or distant recurrence (P = .18). We conclude that radiation therapy saves some patients from local recurrence. However, our data suggest that, for women with small unifocal tumors without axillary lymph node involvement, a meticulous surgical technique may be an alternative to surgery plus routine radiotherapy.
Medical subject headings
- Breast Neoplasms